v3.26.1
Share-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Compensation [Abstract]  
Schedule of Valuing the Restricted Shares with Post-Vesting Restrictions on Grant Dates

The weighted average grant date fair value is $4.10 and $4.24 for the years ended December 31, 2025 and 2024. The following are the assumptions used in valuing the restricted shares with post-vesting restrictions on grant dates during the years ended December 31, 2024 (in percentages, except as noted):

 

   For the
Year Ended
December 31,
2024		 
     
Expected stock price volatility   143.42 - 150.32 
Weighted average expected life (in years)   1 
Dividend yield   
-
 
Discount for Post-Vesting Restrictions   13.46 - 13.79 
Schedule of Nonvested Shares

A summary of changes in the Company’s nonvested shares for the year follows:

 

    Number of shares     Weighted-
Average
Grant-
Date
Per Share
Fair Value		  
             
Balance at January 1, 2024    
-
     $
-
  
Granted     6,512,781       4.24  
Vested     (6,176,756 )     4.22  
Forfeited     (10,919 )     5.05  
Non-vested at December 31, 2024     325,106     $ 5.05  
Granted     44,260     $ 4.10  
Vested     (118,177 )     4.30  
Forfeited     (45,802 )     5.05  
Non-vested at December 31, 2025     205,387     $ 4.95  
Schedule of Share-Based Compensation Expenses Related to Restricted Shares

The share-based compensation expenses related to restricted shares are recorded as components of general and administrative expenses, selling and marketing expenses, and research and development expenses, as follows:

 

   Year Ended December 31 
   2025   2024   2023 
             
General and administrative expenses   398    17,617    
-
 
Selling and marketing expenses   135    4,502    
-
 
Research and development expenses   55    3,946    
-
 
Total   588    26,065    
-